A Study of Peginterferon Alfa-2b Combined With TDF in Patients With Chronic Hepatitis B
Clinical trial NCT04846491 · COMPLETED
Trial details
- NCT number
- NCT04846491
- Sponsor
- Xiamen Amoytop Biotech Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-04
- Primary completion
- 2023-11-30
- Enrollment
- 475
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.